iOAT-APP: injectable Opioid Agonist Therapy Administration in a Pregnant or perinatal Population

Who is conducting this study?

This study is led by Investigators at the Women’s Health Research Institute, in association with the University of British Columbia, and the University of Victoria, including: Dr. Charissa Patricelli, Dr. Karen Urbanoski, Dr. Arianne Albert, and Nicole Carter. This work is being conducted in collaboration with Peer Research Associates with lived and living experience with substance use in pregnancy.

About the iOAT-APP study

Injectable opioid agonist therapy (“iOAT”) is a high intensity treatment option for people who would like to stabilize from opioid use. Although there is a lot of research supporting iOAT as an effective treatment, there is little research on iOAT in pregnancy. This research study is interested in understanding how women who are offered iOAT feel about this treatment, and exploring the health and social outcomes for mothers and their babies.

Participation

Patients at FIR at BC Women’s Hospital who are offered iOAT as part of their standard clinical care are invited to participate in this study. Participants will be asked to complete 4 study visits over the course of three months. Study visits include surveys, and an interview with a study team member.

4) Study Findings: The study is currently enrolling participants. Please continue to revisit this page to receive updates on the study.

Study findings

The study is currently enrolling participants. Please continue to revisit this page to receive updates on the study.

Investigators

  • Charissa Patricelli, MD, Medical Director, Perinatal Addictions, Department of Family Practice, BC Women’s Hospital (Principal Investigator)
  • Karen Urbanoski, PhD, Associate Professor, Department of Public Health and Social Policy, University of Victoria
  • Arianne Albert, PhD, Senior Biostatistician, Department of Obstetrics and Gynaecology, Women’s Health Research Institute
  • Nicole Carter, RN, Patient Care Coordinator, FIR, BC Women’s Hospital

The Women’s Health Research Institute would like to acknowledge that we are uninvited guests on the unceded ancestral territories of the xʷməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lo, and sel̓íl̓witulh (Tsleil-waututh) Nations.

As a provincial research institute committed to improving the health outcomes of women, including those across the 2SLGBTQIA+ spectrum, we recognize our responsibility in the collective effort towards establishing culturally safe health care systems and services that address health inequities among Indigenous peoples, especially Indigenous women, girls, and Two-spirit peoples.

We encourage all people involved in research to read both the Truth and Reconciliation Commission of Canada: Calls to Action and the In Plain Sight Report, and reflect on ways we can incorporate the recommendations into our work. As we gather in spaces together, we encourage you to reflect on your positionality on these lands and your personal commitments to reconciliation.

Top
WHRI Menu
WHRI Menu